神经保护
MPTP公司
肠道菌群
丁酸钠
帕金森病
肠-脑轴
TLR4型
丁酸盐
药理学
免疫学
神经科学
生物
医学
内科学
信号转导
细胞生物学
疾病
生物化学
基因
发酵
作者
Tongtong Guo,Zheng Zhang,Yan Sun,Rui-Yang Zhu,Fei-Xia Wang,Lianju Ma,Lin Jiang,Han-Deng Liu
出处
期刊:Nutrients
[Multidisciplinary Digital Publishing Institute]
日期:2023-02-13
卷期号:15 (4): 930-930
被引量:106
摘要
Parkinson's disease (PD) is a prevalent type of neurodegenerative disease. There is mounting evidence that the gut microbiota is involved in the pathogenesis of PD. Sodium butyrate (NaB) can regulate gut microbiota and improve brain functioning in neurological disorders. Hence, we examined whether the neuroprotective function of NaB on PD was mediated by the modulation of gut microbial dysbiosis and revealed its possible mechanisms. Mice were administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) for 7 consecutive days to construct the PD model. NaB gavage was given 2 h after the daily MPTP injections for 21 days. NaB improved the motor functioning of PD mice, increased striatal neurotransmitter levels, and reduced the death of dopaminergic neurons. The 16S rRNA sequencing analysis revealed that NaB restored the gut microbial dysbiosis. NaB also attenuated the intestinal barrier's disruption and reduced serum, colon, and striatal pro-inflammatory cytokines, along with inhibiting the overactivation of glial cells, suggesting an inhibitory effect on inflammation from NaB throughout the gut-brain axis of the PD mice. Mechanistic studies revealed that NaB treatment suppressed the TLR4/MyD88/NF-kB pathway in the colon and striatum. In summary, NaB had a neuroprotective impact on the PD mice, likely linked to its regulation of gut microbiota to inhibit gut-brain axis inflammation.
科研通智能强力驱动
Strongly Powered by AbleSci AI